主動脈是人體內*大的動脈，把含氧的血液由心臟輸送到全身各個部位。位于血管壁的主動脈內皮細胞（AEC）經常暴露于高血流動力，誘導內皮源性血管收縮和血管生長調節的物質生產變化。AEC也調節細胞粘附分子的表達來控制和微調的炎癥反應和纖溶系統。這些生理特征使得AEC廣泛被應用于研究內皮功能障礙機理、血管疾病和動脈硬化的發病機理、以及新的疾病的治療技術的發展。
Sciencell研究實驗室的ACE是從人主動脈分離得到的，原代凍存，冰凍運輸。每管細胞密度超過5×10^5/ml。細胞特性經vWF/Factor VIII和CD31 (PECAM) 免疫熒光鑒定，能夠攝取DiI標記乙酰化低密度脂蛋白(DiI-Ac-LDL)。本細胞經檢測不含HIV-1、HBV、HCV、支原體、細菌、酵母菌和真菌。如采用ScienCell 實驗室特制的培養基，可保證此細胞10倍增增殖。
推薦培養基：成纖維細胞培養基 (FM, Cat. #2301)
|
貨號
|
6100
|
|
產地
|
美國
|
|
縮寫
|
HAEC
|
|
規格
|
5 x 10^5 /1ml
|
|
用途
|
科研
|
|
儲存
|
液氮
|
|
運輸
|
干冰
|
|
關鍵字
|
人主動脈內皮細胞 HAEC 人主動脈內皮細胞 HAEC 人主動脈內皮細胞 HAEC 人主動脈內皮細胞 HAEC 人主動脈內皮細胞 HAEC 人主動脈內皮細胞 HAEC 人主動脈內皮細胞 HAEC 人主動脈內皮細胞 HAEC
|
公司簡介
|
合肥星肽生物科技有限公司作為專業的ScienCell中國代理商，專業經營實驗室科研用原代細胞、原代細胞專用培養基、原代細胞無血清培養基、干細胞、干細胞培養基、干細胞無血清培養基的研究和開發。合肥星肽生物科技有限公司始終致力于為客戶提供可靠的研究材料以及方便快捷的服務，對購買項目的前期資料提供,中期合同保證,后期貨物跟蹤到 *終售后的確保項目準確到位，都有相關專業人士進行維護,確保您在合肥合肥星肽生物科技有限公司公司獲得*上等服務！
|
|
聯系方式
|
何經理，合肥星肽生物科技有限公司，Tel：0551-63802898 400-8702-898，
E-mail：info@qingbio.com http://m.qkdn.cn QQ:514713116
|
1.) Zhao N, Watson N, Xu Z, Chen Y, Waterman J, Sankar J, Zhu D. (2014) "In Vitro Biocompatibility and Endothelialization of Novel Magnesium-Rare Earth Alloys for Improved Stent Applications." PloS one. 9: e98674.
2.) Wang W, Deng M, Liu X, Ai W, Tang Q, Hu J. (2011) "TLR4 Activation Induces Nontolerant Inflammatory Response in Endothelial Cells." Inflammation. 34: 509-18.
3.) Cai W, Torreggiani M, Zhu L, Chen X, He JC, Striker GE, Vlassara H. (2010) "AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease." Am J Physiol Cell Physiol. 298: C624-34.
4.) Kong DK, Georgescu SP, Cano C, Aronovitz MJ, Iovanna JL, Patten RD, Kyriakis JM, Goruppi S. (2010) "Deficiency of the transcriptional regulator p8 results in increased autophagy and apoptosis, and causes impaired heart function." Mol Biol Cell. 21: 1335-49.
5.) Shahani T, Lavend'homme R, Luttun A, Saint-Remy JM, Peerlinck K, Jacquemin M. (2010) "Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool." Blood. 115: 4902-9.
6.) Zhang CL, Song F, Zhang J, Song QH. (2010) "Hypoxia-induced Bcl-2 expression in endothelial cells via p38 MAPK pathway." Biochem Biophys Res Commun. 394: 976-80.
7.) Linden E, Cai W, He JC, Xue C, Li Z, Winston J, Vlassara H, Uribarri J. (2008) "Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation." Clin J Am Soc Nephrol. 3: 691-8.
8.) Zhang X, Baughman CB, Kaplan DL. (2008) "In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth." Biomaterials. 29: 2217-27.
9.) Gentry M, Taormina J, Pyles RB, Yeager L, Kirtley M, Popov VL, Klimpel G, Eaves-Pyles T. (2007) "Role of Primary Human Alveolar Epithelial Cells in Host Defense against Francisella tularensis Infection." Infect Immun. 75: 3969-78.
10.) Simard JM, Tsymbalyuk O, Ivanov A, Ivanova S, Bhatta S, Geng Z, Woo SK, Gerzanich V. (2007) "Endothelial sulfonylurea receptor 1-regulated NCCa-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury." J Clin Invest. 117: 2105-13.
There are no product questions yet.
